Overview
Setting the Next
Biotech Standard
novel antibody-based therapies engineered for definitive therapeutic impact.
We start with the most critical unmet medical needs,
leveraging patient-derived data and models to translate deep clinical insights into reality.
Born from the front lines of clinical care as a spin-off from Samsung Medical Center, one of world’s leading centers*
we directly confront the challenges seen in the clinic.
We pursue a global standard of drug development by focusing exclusively on candidates with the highest probability
of clinical significance, rigorously validated through our patient-centric engine.
In the field of antibody therapeutics, including ADCs,
our core benchmarks are scientific integrity and clinical relevance.
This ensures we are creating medicines that can deliver a tangible, transformative difference for patients.
Ultimately, AimedBio seeks to define the future of biotechnology
by delivering truly meaningful therapeutic options to patients.
